Compliance with hypertensive therapy [3]

Hypertension

Volumn 48, Issue 4, 2006, Pages

  David, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; CLINICAL MEDICINE; DRUG COST; DRUG FORMULARY; DRUG TOLERABILITY; EVALUATION; HEALTH MAINTENANCE ORGANIZATION; HUMAN; HYPERTENSION; LETTER; MEDICARE; NATIONAL HEALTH INSURANCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRIVATE PRACTICE; UNSPECIFIED SIDE EFFECT; BEHAVIORAL RESEARCH; METHODOLOGY; NOTE;

BEHAVIORAL RESEARCH; HUMANS; HYPERTENSION; PATIENT COMPLIANCE;

EID: 33750600492     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000239674.65561.7f     Document Type: Letter

References (2)

1. Halpern MT, Kahn ZM, Schmier JR, Burnier M, Caro JJ, Cramer J, Daley WL, Gurvitz J, Hollenberg. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006;47:1039-1048.
2. David, David S. Cigarette smoking: how much worse can it get? Circulation. 2001;25:e128.